Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate tablets, 5 mg,cll
HealthData.Gov
Updated Mar 24, 2026
About this dataset
This generic medication, approved under ANDA207388 by Alvogen Inc., contains a combination of amphetamine salts (dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate) in oral tablet form. It's a Schedule II controlled substance, available in strengths equivalent to 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg, and 30 mg of amphetamine, used as a central nervous system stimulant. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate tablets, 5 mg,cll
Access the FDA dataset for Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate tablets, 5 mg,cll — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025
Related datasets
- Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate tablets, 5 mg,cllHealthData.Gov
- Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfateHealthData.Gov
- Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfateHealthData.Gov
- Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfateHealthData.Gov
- Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfateHealthData.Gov